Vascular mechanobioengineering

心血管疾病是社会的一个重要负担。动脉粥样硬化斑块早在儿童时期就已形成，全身性风险因素已被确定，沿着出现了潜在的预防和治疗途径。鉴于当前的大流行，努力的目标是通过生物标志物识别和分子成像开发进行诊断，以及通过开发新分子进行治疗。

Cardiovascular diseases represent an important burden for society. Atherosclerotic plaques develop as early as childhood and systemic risk factors have been identified, along with potential preventative and therapeutic avenues. Given the current pandemic, efforts are targeted towards diagnosis, through biomarker identification and molecular imaging development, and treatment, by developing novel molecules.